Autism
The funds will be used to accelerate the company's innovation, expand its workforce and bolster support for applied behavior analysis providers.
The company's AI-powered platform aims to help clinicians diagnose and treat children with autism and related disorders.
The program will focus on decreasing the rate of canceled medical appointments by autistic individuals using oVRcome's VR-based exposure therapy platform.
The company will use the funds to grow its autism therapy practice, continue AI and LLM research, and develop clinical algorithms.
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
The platform connects adults with conditions like autism, ADHD, OCD or Tourette's with care teams trained to help with their specific needs.
EarliPoint Evaluation monitors a child's looking behavior while watching videos to help a clinician identify autism spectrum disorder.
Also: Autism-focused SpectrumAi and cancer clinical trial platform Massive Bio both scooped up $9 million.
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
The Atlanta-based startup uses digital biomarkers to help detect for developmental disorders.